SUNSHINE BIOPHARMA INC (SBFM) Stock Price & Overview
NASDAQ:SBFM • US8677817004
The current stock price of SBFM is 1.19 USD. Today SBFM is down by 0%. In the past year, price decreased by -38.34%.
SBFM Key Statistics
- Market Cap
- 5.843M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -51.88
- Dividend Yield
- N/A
SBFM Stock Performance
SBFM Stock Chart
SBFM Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to SBFM. When comparing the yearly performance of all stocks, SBFM is a bad performer in the overall market: 87.06% of all stocks are doing better.
SBFM Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to SBFM. The financial health of SBFM is average, but there are quite some concerns on its profitability.
SBFM Earnings
On November 13, 2025 SBFM reported an EPS of -0.19 and a revenue of 9.42M. The company missed EPS expectations (-43.29% surprise) and missed revenue expectations (-16.82% surprise).
SBFM Forecast & Estimates
7 analysts have analysed SBFM and the average price target is 6.12 USD. This implies a price increase of 414.29% is expected in the next year compared to the current price of 1.19.
For the next year, analysts expect an EPS growth of 98.01% and a revenue growth -0.21% for SBFM
SBFM Groups
Sector & Classification
SBFM Financial Highlights
Over the last trailing twelve months SBFM reported a non-GAAP Earnings per Share(EPS) of -51.88. The EPS increased by 88.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -19.03% | ||
| ROE | -24.76% | ||
| Debt/Equity | 0 |
SBFM Ownership
SBFM Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.37 | 401.392B | ||
| AMGN | AMGEN INC | 16.53 | 202.383B | ||
| GILD | GILEAD SCIENCES INC | 16.82 | 184.425B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.35 | 126.804B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.65 | 81.619B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.89 | 42.754B | ||
| INSM | INSMED INC | N/A | 31.007B | ||
| NTRA | NATERA INC | N/A | 28.197B | ||
| BIIB | BIOGEN INC | 11.98 | 27.651B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.21 | 23.485B | ||
| MRNA | MODERNA INC | N/A | 21.714B | ||
| EXAS | EXACT SCIENCES CORP | 340.09 | 19.732B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.591B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SBFM
Company Profile
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. The company is headquartered in Fort Lauderdale, Florida and currently employs 52 full-time employees. The company went IPO on 2008-08-15. The firm has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The firm operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The firm operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
Company Info
IPO: 2008-08-15
SUNSHINE BIOPHARMA INC
333 Las Olas Way, Cu4 Suite 433
FORT LAUDERDALE FLORIDA US
Employees: 52
Phone: 19543300684
SUNSHINE BIOPHARMA INC / SBFM FAQ
Can you describe the business of SUNSHINE BIOPHARMA INC?
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. The company is headquartered in Fort Lauderdale, Florida and currently employs 52 full-time employees. The company went IPO on 2008-08-15. The firm has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The firm operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The firm operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
Can you provide the latest stock price for SUNSHINE BIOPHARMA INC?
The current stock price of SBFM is 1.19 USD.
Does SUNSHINE BIOPHARMA INC pay dividends?
SBFM does not pay a dividend.
How is the ChartMill rating for SUNSHINE BIOPHARMA INC?
SBFM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How is the valuation of SUNSHINE BIOPHARMA INC (SBFM) based on its PE ratio?
SUNSHINE BIOPHARMA INC (SBFM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-51.88).
What is the employee count for SBFM stock?
SUNSHINE BIOPHARMA INC (SBFM) currently has 52 employees.
What is SUNSHINE BIOPHARMA INC worth?
SUNSHINE BIOPHARMA INC (SBFM) has a market capitalization of 5.84M USD. This makes SBFM a Nano Cap stock.